SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-16-000119
Filing Date
2016-05-16
Accepted
2016-05-16 16:34:31
Documents
13
Period of Report
2016-05-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kinitialmor_05162016.htm 8-K 32676
2 EXHIBIT 99.1 nrxinitialmora01.htm EX-99.1 14213
3 nrxinitialmora01001.jpg GRAPHIC 88229
4 nrxinitialmora01002.jpg GRAPHIC 8752
5 nrxinitialmora01003.jpg GRAPHIC 130046
6 nrxinitialmora01004.jpg GRAPHIC 81021
7 nrxinitialmora01005.jpg GRAPHIC 250100
8 nrxinitialmora01006.jpg GRAPHIC 56766
9 nrxinitialmora01007.jpg GRAPHIC 134809
10 nrxinitialmora01008.jpg GRAPHIC 143713
11 nrxinitialmora01009.jpg GRAPHIC 109789
12 nrxinitialmora01010.jpg GRAPHIC 48712
13 nrxinitialmora01011.jpg GRAPHIC 88410
  Complete submission text file 0001338095-16-000119.txt   1607477
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 161654446
SIC: 2834 Pharmaceutical Preparations